NO920624D0 - Reagens for paavisning av fibrinolytisk aktivitet - Google Patents

Reagens for paavisning av fibrinolytisk aktivitet

Info

Publication number
NO920624D0
NO920624D0 NO920624A NO920624A NO920624D0 NO 920624 D0 NO920624 D0 NO 920624D0 NO 920624 A NO920624 A NO 920624A NO 920624 A NO920624 A NO 920624A NO 920624 D0 NO920624 D0 NO 920624D0
Authority
NO
Norway
Prior art keywords
antibody
fibrinolytic enzyme
fibrinolytic
reagent
determination
Prior art date
Application number
NO920624A
Other languages
English (en)
Norwegian (no)
Other versions
NO920624L (no
Inventor
Johan Selmer
Niels Tromholt
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO920624L publication Critical patent/NO920624L/no
Publication of NO920624D0 publication Critical patent/NO920624D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9726—Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO920624A 1989-08-18 1992-02-17 Reagens for paavisning av fibrinolytisk aktivitet NO920624D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK408289A DK408289D0 (da) 1989-08-18 1989-08-18 Diagnostisk reagens
PCT/DK1990/000210 WO1991002546A1 (en) 1989-08-18 1990-08-16 A reagent for the detection of fibrinolytic activity

Publications (2)

Publication Number Publication Date
NO920624L NO920624L (no) 1992-02-17
NO920624D0 true NO920624D0 (no) 1992-02-17

Family

ID=8129992

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920624A NO920624D0 (no) 1989-08-18 1992-02-17 Reagens for paavisning av fibrinolytisk aktivitet

Country Status (18)

Country Link
US (1) US5165912A (da)
EP (1) EP0487594B1 (da)
JP (1) JPH04507254A (da)
KR (1) KR920703120A (da)
AT (1) ATE92770T1 (da)
AU (1) AU639940B2 (da)
CA (1) CA2065147A1 (da)
CZ (1) CZ280904B6 (da)
DD (1) DD297064A5 (da)
DE (1) DE69002769T2 (da)
DK (2) DK408289D0 (da)
ES (1) ES2058931T3 (da)
FI (1) FI920669A0 (da)
IE (1) IE65525B1 (da)
IL (1) IL95407A (da)
NO (1) NO920624D0 (da)
NZ (1) NZ234937A (da)
WO (1) WO1991002546A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964764B2 (en) * 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6355243B1 (en) 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US20080167544A1 (en) * 2006-12-01 2008-07-10 Cold Spring Diagnostics, Inc. Compositions And Methods For Locating An Internal Bleeding Site
UA103771C2 (ru) * 2008-06-04 2013-11-25 Грифолз Терапьютикс Инк. Стрептокиназа, активирующая плазмин, способ и набор для получения плазмина
JP5789521B2 (ja) 2009-03-03 2015-10-07 グリフオルス・セラピユーテイクス・インコーポレーテツドＧｒｉｆｏｌｓ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． プラスミノーゲンを製造するための組成物、方法およびキット；ならびにそれから製造されるプラスミン

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0169232B1 (en) * 1984-01-23 1990-04-25 For Energiteknikk Institutt Composition for technetium-99m labelling of proteinaceous material
US4659839A (en) * 1984-10-10 1987-04-21 Mallinckrodt, Inc. Coupling agents for radiolabeled antibody fragments
CA1285223C (en) * 1986-11-10 1991-06-25 New England Deaconess Hospital Detection of vascular disease

Also Published As

Publication number Publication date
CZ280904B6 (cs) 1996-05-15
IL95407A0 (en) 1991-06-30
DD297064A5 (de) 1992-01-02
DE69002769T2 (de) 1993-12-02
US5165912A (en) 1992-11-24
JPH04507254A (ja) 1992-12-17
NZ234937A (en) 1991-11-26
ATE92770T1 (de) 1993-08-15
KR920703120A (ko) 1992-12-17
ES2058931T3 (es) 1994-11-01
NO920624L (no) 1992-02-17
AU6285990A (en) 1991-04-03
CZ404790A3 (en) 1996-01-17
DE69002769D1 (de) 1993-09-16
DK408289D0 (da) 1989-08-18
WO1991002546A1 (en) 1991-03-07
FI920669A7 (fi) 1992-02-17
CA2065147A1 (en) 1991-02-19
IL95407A (en) 1994-07-31
FI920669A0 (fi) 1992-02-17
IE65525B1 (en) 1995-11-01
DK0487594T3 (da) 1994-01-03
IE902977A1 (en) 1991-02-27
AU639940B2 (en) 1993-08-12
EP0487594A1 (en) 1992-06-03
EP0487594B1 (en) 1993-08-11

Similar Documents

Publication Publication Date Title
AU629903B2 (en) Mitomycin c derivatized with a hapten
SE8902638L (sv) Stabiliserade protein- eller peptidkonjugat
DE69128791D1 (de) Modifizierte antikörper mit kontrollierter clearance-zeit
EP0259857A3 (en) Method of assaying physiologically active substances
FI103976B1 (fi) Menetelmä insuliinista riippuvan diabetes mellituksen (IDDM:n) diagnosoimiseksi in vitro ja siinä käyttökelpoinen välineistö ja polypeptidi
DE69822164D1 (de) Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität
SE7903821L (sv) Kinetisk metning av glykoskoncentrationen i kroppsvetskor och beredning herfor
NZ332641A (en) method of detecting a lysosomal storage disorder by assaying the level of an enzyme, protein or peptide associated with the disease
FI920669A0 (fi) Reagens foer detektion av fibrinolytisk aktivitet.
EP0295402A3 (en) Latex for immobilization of physiologically active substance and latex reagent using the latex
NO173336C (no) Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein
ES8707798A1 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
DK112290A (da) Vaevsplasminogenaktivator-variant
EP0313005A3 (en) Method for detecting carcinomatous and precarcinomatous colo-rectal disease
DE69027441D1 (en) Ribozymenhemmer
AU573748B2 (en) Monoclonal antibody to cancer procoagulant and immunoassay
JPS57148253A (en) Quantitative kit for cancer resisting agent
IE873143L (en) HOMOGENEOUS SHEEP TllTS AS AN INTERMEDIATE FOR THE¹PREPARATION OF HUMAN Tllts, AND THE USE THEREOF
EP0241000A3 (en) Method for determination of complements
Taran et al. Method of determining factor IX activity
RU98112436A (ru) Способ определения фибринолитической активности мочи
JPS57163319A (en) Preparation of antibody
NO177310C (no) Antigent polypeptid fra HBxAg, antistoff som reagerer med polypeptidet, diagnostisk analysesystem for bestemmelse av tilstedeværelsen av HBxAg i en kroppspröve, samt anvendelse av polypeptidet til in vitro diagnose
DK389584A (da) Fremgangsmaade til maerkning af fagocytceller
SU1688679A1 (ru) Способ измерения уровня клозапина в сыворотке крови